The majority of documents to the left pertain to lupron and the field of assisted reproductive technologies (ART), but information regarding the problems with the initial endometriosis clinical trials can be found within my 'USA Draft Document'. It might be useful for women to understand the problems the prostate cancer clinical trials faced as well, therefore I would suggest reading the 'male approval' section in this document also.

At present, this page contains mostly my letters, their responses, and my MA. and Congressional testimonies pertaining to the risks of lupron and ART. Beginning in 1992, I attempted to ask questions and bring attention to the various problems involved with this issue. With a few exceptions, most of the responses fail to directly answer the questions, but I'll be putting these letters and responses in the public domain to illustrate just one woman's attempt to ask these questions. (Perhaps you too have written questions to the same people and agencies that I have).

My horrendous experience at the hands of the Fertility Industry brought me face to face with a totally unregulated field (no standards, no laws, only minimum guidelines that may or may not be followed), and I became involved in drafting a piece of legislation to correct these problems (MA. H. #1833). This bill was opposed by the Fertility Industry and eventually died, but my MA. testimonies (1992 - 1999) are a testament to the learning curve regarding the risks of lupron and ART: in '92 I thought IVF was an "admirable" technology ... but shortly thereafter, 'endocriminologist' was coined.

Other documents on this page are my comments concerning risks to women from embryonic stem cell research (ESCR), focusing on the risks from lupron/leuprolide.

This page is under construction.